Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

morgan-stanley-maintains-overweight-on-affirm-holdings,-inc.-(afrm)-mar-2026

Morgan Stanley Maintains Overweight on Affirm Holdings, Inc. (AFRM) Mar 2026

Mar 5, 2026

Morgan Stanley maintained an Overweight rating on Affirm Holdings, Inc. (AFRM) on March 04, 2026. This AFRM analyst…

Read more
ubs-maintains-cautious-on-cricut,-inc.-(crct)-march-04,-2026

UBS Maintains Cautious on Cricut, Inc. (CRCT) March 04, 2026

Mar 5, 2026

Get analyst ratings, AI forecasts, and market updates in your inbox every morning. 12% average open rate and…

Read more
jefferies-reiterates-buy-on-the-boeing-company-(ba)-march-04,-2026

Jefferies Reiterates Buy on The Boeing Company (BA) March 04, 2026

Mar 4, 2026

Jefferies reiterated a Buy on The Boeing Company (BA) on March 04, 2026, a move that keeps analyst…

Read more
this-spx-technologies-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-wednesday

This SPX Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Mar 4, 2026

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
bloom-energy-rises-as-wall-street-refocuses-on-ai-data-center-power-demand-and-fresh-analyst-coverage

Bloom Energy rises as Wall Street refocuses on AI data-center power demand and fresh analyst coverage

Mar 4, 2026

Bloom Energy (BE) is up 6.9% today. Here is some analysis on what might have caused this price…

Read more
cowen-maintains-hold-on-oii;-oceaneering-international,-inc.-pt-$34-mar-3,-2026

Cowen Maintains Hold on OII; Oceaneering International, Inc. PT $34 Mar 3, 2026

Mar 4, 2026

Cowen & Co. maintained a Hold on OII and raised its price target to $34 on March 03,…

Read more
wedbush-maintains-outperform-on-larimar-therapeutics,-inc.-(lrmr)-march-2026

Wedbush Maintains Outperform on Larimar Therapeutics, Inc. (LRMR) March 2026

Mar 4, 2026

On March 03, 2026 Wedbush maintained an Outperform rating on Larimar Therapeutics, Inc. (LRMR) and raised its price…

Read more
benchmark-maintains-buy-on-calm-(cal-maine-foods,-inc.)-march-03,-2026

Benchmark Maintains Buy on CALM (Cal-Maine Foods, Inc.) March 03, 2026

Mar 4, 2026

Get analyst ratings, AI forecasts, and market updates in your inbox every morning. 12% average open rate and…

Read more
stronger-q4-earnings-and-analyst-coverage-might-change-the-case-for-investing-in-healthcare-services-group-(hcsg)

Stronger Q4 Earnings and Analyst Coverage Might Change The Case For Investing In Healthcare Services Group (HCSG)

Mar 4, 2026

Recently, Healthcare Services Group reported strong fourth-quarter results with better-than-expected adjusted EBITDA, prompting RBC Capital to begin coverage…

Read more
ubs-maintains-buy-on-rl-(ralph-lauren-corporation)-march-03,-2026

UBS Maintains Buy on RL (Ralph Lauren Corporation) March 03, 2026

Mar 4, 2026

On March 03, 2026 UBS maintained its Buy rating on Ralph Lauren Corporation (RL), a clear headline for…

Read more
bofa-maintains-neutral-on-asts-(ast-spacemobile,-inc.)-march-03,-2026

BofA maintains Neutral on ASTS (AST SpaceMobile, Inc.) March 03, 2026

Mar 4, 2026

Get analyst ratings, AI forecasts, and market updates in your inbox every morning. 12% average open rate and…

Read more
benchmark-maintains-buy-on-surgery-partners-(sgry)-march-3,-2026

Benchmark Maintains Buy on Surgery Partners (SGRY) March 3, 2026

Mar 4, 2026

Benchmark maintained its Buy rating on Surgery Partners, Inc. (SGRY) on March 3, 2026. The note followed Q4…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 17
  6. 18
  7. 19
  8. 20
  9. 21
  10. 22
  11. 23
  12. ...
  13. 377
  14. »

Posts pagination

Newer posts Page 1 … Page 20 … Page 377 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.